STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
Recruiting
- Waldenstrom Macroglobulinemia
- DASATINIB
- Boston, MassachusettsDana Farber Cancer Institute
2022-03-22
Mar 22, 2022M
Suspended
- Recurrent Waldenstrom Macroglobulinemia
- +2 more
- Ibrutinib
- +4 more
- Jacksonville, Florida
- +1 more
2021-08-02
Aug 2, 2021D
Active, not recruiting
- Multiple Myeloma
- +3 more
- Boston, MassachusettsDana-Farber Cancer Institute
2022-03-15
Mar 15, 2022S
Recruiting
- Waldenstrom Macroglobulinemia
- Loncastuximab Tesirine
- Dexamethasone
- Boston, MassachusettsDana Farber Cancer Institute
2022-03-01
Mar 1, 2022D
Active, not recruiting
- Waldenstrom Macroglobulinemia
- MYD88 Gene Mutation
- Boston, Massachusetts
- +1 more
2022-04-01
Apr 1, 2022C
Recruiting
- Hyperviscosity Syndrome
- Waldenstrom Macroglobulinemia
- fundoscopic picture
- +2 more
- Amiens, FranceCHU Amiens
2021-05-19
May 19, 2021U
Active, not recruiting
- Chronic Lymphocytic Leukemia (CLL)
- Waldenstrom Macroglobulinemia (WM)
- Shingrix vaccine
- Rochester, New YorkUniversity of Rochester
2022-02-07
Feb 7, 2022U
Not yet recruiting
- Waldenstrom Macroglobulinemia
- Venetoclax; Rituximab
- DRC
- (no location specified)
2022-03-09
Mar 9, 2022D
Active, not recruiting
- Waldenstrom Macroglobulinemia
- Duarte, California
- +3 more
2021-04-17
Apr 17, 2021A
Recruiting
- Waldenstrom Macroglobulinemia
- APG2575 400 mg
- +2 more
- Duarte, California
- +5 more
2022-02-28
Feb 28, 2022W
Recruiting
- Waldenstrom Macroglobulinemia
- +6 more
- New York, New YorkWeill Cornell Medicine
2021-12-21
Dec 21, 2021C
Recruiting
- Waldenstrom's Disease
- Waldenstrom Macroglobulinemia
- bone marrow sample
- blood sample
- Amiens, FranceCHU Amiens
2021-05-17
May 17, 2021C
Completed
- Waldenström Macroglobulinemia
- Blood or bone marrow samples
- Vandoeuvre les Nancy, FranceCHRU Nancy
2021-08-01
Aug 1, 2021M
Not yet recruiting
- Multiple Myeloma
- +3 more
- Boston, Massachusetts
- +1 more
2021-03-31
Mar 31, 2021D
Active, not recruiting
- Waldenström Macroglobulinemia
- Boston, Massachusetts
- +4 more
2021-04-21
Apr 21, 2021G
Terminated
- Waldenstrom Macroglobulinemia
- Epratuzumab (hLL2- anti-CD22 humanized antibody)
- New York, New York
- +1 more
2021-08-12
Aug 12, 2021F
Active, not recruiting
- Waldenstrom Macroglobulinemia
- Tours, FranceProject manager
2021-06-28
Jun 28, 2021J
Recruiting
- IgM MGUS
- +2 more
- Boston, Massachusetts
- +1 more
2022-02-16
Feb 16, 2022E
Recruiting
- IgA Monoclonal Gammopathy
- +8 more
- Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
2021-10-18
Oct 18, 2021J
Active, not recruiting
- Waldenstrom Macroglobulinemia
- Changchun, China
- +5 more
2022-03-24
Mar 24, 2022N
Recruiting
- Waldenstrom Macroglobulinemia
- +4 more
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022S
Recruiting
- Waldenstrom Macroglobulinemia
- Acalabrutinib
- +2 more
- Vancouver, British Columbia, Canada
- +3 more
2021-07-23
Jul 23, 2021J
Active, not recruiting
- Waldenstrom Macroglobulinemia
- Chiba, Japan
- +8 more
2022-03-24
Mar 24, 2022K
Recruiting
- Waldenström's Macroglobulinemia
- Lenalidomide, Bortezomib, Rituximab, Dexamethasone
- Busan, Sue-gu, Korea, Republic ofKosin University Gospel Hospital
2022-03-31
Mar 31, 2022T
Active, not recruiting
- Waldenstrom Macroglobulinemia
- Washington, District of Columbia
- +3 more
2022-03-22
Mar 22, 2022